Alisertib treatment of relapsed or refractory peripheral T-cell lymphoma: disappointing results

被引：0
|
作者：
Paillassa, Jerome
机构：
来源：
HEMATOLOGIE | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：130 / 131
页数：2
相关论文
共 50 条
  • [41] A Phase II Study of Nivolumab in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
    Bennani, N. Nora
    Pederson, Levi D.
    Atherton, Pamela
    Micallef, Ivana
    Colgan, Joseph P.
    Thanarajasingam, Gita
    Nowakowski, Grzegorz
    Witzig, Thomas E.
    Feldman, Andrew L.
    Ansell, Stephen M.
    BLOOD, 2019, 134
  • [42] Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma
    Foss, Francine
    Pro, Barbara
    Miles Prince, H.
    Sokol, Lubomir
    Caballero, Dolores
    Horwitz, Steven
    Coiffier, Bertrand
    CANCER MEDICINE, 2017, 6 (01): : 36 - 44
  • [43] A Phase Ib Study of Linperlisib in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
    Jin, Jie
    Cen, Hong
    Zhou, Keshu
    Xu, Xiaohong
    Li, Fei
    Yang, Haiyan
    Li, Zhiming
    Bao, Hanying
    Xu, Zusheng
    Qiu, Lugui
    Shu, Yang
    Li, Fei
    Wang, Zhen
    BLOOD, 2021, 138
  • [44] PRALATREXATE IN PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA; REPORT ON THREE PATIENTS
    Tezel, Pinar
    Bulbul, Hale
    Koseoglu, Fatos Dilan
    Davulcu, Eren Arslan
    Ulusoy, Yusuf
    Soyer, Nur Akad
    Sahin, Fahri
    Tombuloglu, Murat
    Saydam, Guray
    LEUKEMIA RESEARCH, 2017, 61 : S51 - S51
  • [45] The Novel Nano-Formulation of the HDAC Inhibitor, Romidepsin, for the Treatment of Relapsed, Refractory Peripheral T-Cell Lymphoma
    Pal, Ipsita
    Illendula, Anuradha
    Manavalan, John Sanil
    Fox, Todd P.
    O'Connor, Owen A.
    Loughran, Thomas P. Jr Jr
    Kester, Mark
    Feith, David J.
    Marchi, Enrica
    BLOOD, 2022, 140 : 8848 - 8849
  • [46] Highly Diverse Efficacy of Salvage Treatment Regimens for Relapsed or Refractory Peripheral T-Cell Lymphoma: A Systematic Review
    Yang, Ya-Ting
    Tai, Cheng-Jeng
    Chen, Chiehfeng
    Wu, Hong-Cheng
    Mikhaylichenko, Natalia
    Chiu, Hsien-Tsai
    Chen, Yun-Yi
    Hsu, Yi-Hsin Elsa
    PLOS ONE, 2016, 11 (10):
  • [47] Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses
    Coiffier, Bertrand
    Pro, Barbara
    Prince, H. Miles
    Foss, Francine
    Sokol, Lubomir
    Greenwood, Matthew
    Caballero, Dolores
    Morschhauser, Franck
    Wilhelm, Martin
    Pinter-Brown, Lauren
    Iyer, Swaminathan Padmanabhan
    Shustov, Andrei
    Nielsen, Tina
    Nichols, Jean
    Wolfson, Julie
    Balser, Barbara
    Horwitz, Steven
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 7
  • [48] Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses
    Bertrand Coiffier
    Barbara Pro
    H Miles Prince
    Francine Foss
    Lubomir Sokol
    Matthew Greenwood
    Dolores Caballero
    Franck Morschhauser
    Martin Wilhelm
    Lauren Pinter-Brown
    Swaminathan Padmanabhan Iyer
    Andrei Shustov
    Tina Nielsen
    Jean Nichols
    Julie Wolfson
    Barbara Balser
    Steven Horwitz
    Journal of Hematology & Oncology, 7
  • [49] Mogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma
    Winsett, Frank T.
    Lewis, Daniel J.
    Duvic, Madeleine
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (09) : 757 - 760
  • [50] Romidepsin Treatment in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: A Systematic Review and Meta-Analysis
    Abdulsattar, Waleed
    Beran, Azizullah
    Alqahtani, Ali
    Abuhelwa, Ziad
    Mhanna, Mohammed
    Alloghbi, Abdurahman
    Srour, Omar
    Ayesh, Hazem
    Hamouda, Danae
    AMERICAN JOURNAL OF THERAPEUTICS, 2022, 29 (05) : E589 - E592
12345